New York, NY -- (SBWIRE) -- 12/22/2021 -- Pediatric patients in need of a valve replacement have historically had few options. There are two solutions that have traditionally been put forward - a purely mechanical valve, which comes with an increased risk of blood clots, and a valve that has been made from animal tissues (a bioprosthetic valve). The major issue that most children have faced with both of these options is outgrowing them. Even the bioprosthetic valve will stop growing once it has been treated to ensure that it is not rejected by the child's immune system. Finding a material that can evolve and grow as a heart valve inside a young patient has been a mission for more than 20 years. Now, a new type of artificial heart valve has been developed that, when transplanted into lambs, actually grew inside the animal. This presents the potential of a valve that can grow with the patient and potentially be populated by their own cells.
EPM Scientific was established in 2012 and provides specialist hiring support to organizations across the life sciences sector, as well as talented people in roles such as medical engineering jobs. The firm's mission is to secure business-critical talent in life sciences and to create opportunities for great minds to innovate and make a difference. Over the years, the firm's field of expertise has expanded into many areas, including medical engineering jobs, clinical development, R&D, commercial, medical communications and quality, regulatory and safety/pharmacovigilance roles. The team works with a broad spectrum of businesses, spanning many different types of organization, from agile start-ups to well-established global life sciences brands. With a database of more than a million mid-to-senior professionals EPM Scientific is well placed to make the right connections happen. The firm combines permanent, contract and multi-hire solutions to create options for every business need.
From New York, to Chicago, Boston, Dallas, Charlotte, Los Angeles and San Francisco, EPM Scientific caters to those in medical engineering jobs, as well as many other roles, all over the country. The USA team is also able to bring a unique international dimension to its work as it is part of a 1,000+ strong worldwide team. Plus, it is the recruitment partner of choice to hundreds of world-leading companies through being part of the Phaidon International group, which operates across 6 countries. This kind of expanded network is vital for the work that the firm is able to do, connecting candidates in areas such as medical engineering jobs with the most exciting opportunities. The internal team at EPM Scientific is a key part of this process - consultants are trained on an ongoing basis and work with best-in-class recruitment technology and strategies. In addition to medical engineering jobs there are many different roles available via the firm today, including Scientific Brand Strategist, Senior Research Associate and Senior Gene Therapy QC Associate.
"Like for many sectors, 2020 marked a defining moment for recruitment. Challenged by uncertainty, but unwavering in our commitment to our clients, we have endured through 2021 with a sense of duty to clients and candidates", commented Kieran Behan, Managing Director at EPM Scientific. He went on to say, "as we reflect on the challenges of virtually securing and retaining talent, we're inspired by a team who have demonstrated a remarkable ability to adapt and continue to help all our clients secure top talent on a global scale."
To find out more about medical engineering jobs visit https://www.epmscientific.com.
For any media inquiries please contact Gary Elliott at Iconic Digital – 020 7100 0726.
For all other inquiries please contact EPM Scientific USA: +1 646 759 4560.
For more information about EPM Scientific services, please go to https://www.epmscientific.com.
About EPM Scientific USA
EPM Scientific USA partners with organizations across the fast-expanding pharmacovigilance sector. The firm's 1000+ employees support growth and development among enterprises where innovation and insight will be crucial to both current and future generations.